Walmsley responds to GSK spin-off rumours

26 July 2018 - Deborah Wilkes

Archived

GlaxoSmithKline's board continues to believe that the company's current structure – based around Consumer Healthcare, Pharmaceuticals and Vaccines businesses – "offers significant opportunities in the current healthcare environment", according to chief executive officer Emma Walmsley.

Click tags below for more information on topics:

GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: